| Insurance Industry | Financials Sector | Mr. Taro Ueno CEO | JPX Exchange | JP3319150003 ISIN |
| Japan Country | 43 Employees | - Last Dividend | - Last Split | - IPO Date |
SUSMED, Inc., established in 2015 and headquartered in Tokyo, Japan, stands at the forefront of the digital therapeutics landscape. The company is dedicated to developing and commercializing innovative therapeutic applications, focusing on enriching patient care through the integration of technology. By harnessing the potential of smartphone-based digital applications, SUSMED aims to address the challenges presented by a variety of diseases, including insomnia, breast cancer, and kidney disease. Alongside its product development efforts, SUSMED extends its expertise to provide medical data analysis and consulting services, driven by a mission to enhance the efficacy of health care solutions through digital innovation.
SUSMED leverages mobile technology to create accessible, user-friendly digital therapies. These applications target a range of conditions, such as insomnia, breast cancer, and kidney disease, providing patients with innovative treatment options that complement traditional medical care. Through the convenience of smartphones, SUSMED's applications aim to facilitate improved health outcomes and enhance the quality of life for individuals facing these health challenges.
The company has developed a versatile platform designed to support the creation of therapeutic applications and the management of clinical trials. This platform is a testament to SUSMED's commitment to advancing digital therapeutics by providing a robust foundation for both development and research. By offering these technical resources, SUSMED empowers researchers and developers to explore new frontiers in medical treatment and healthcare optimization.
Understanding the critical role of data in healthcare, SUSMED provides comprehensive analysis and consulting services. These services are tailored to assist clients in navigating the complexities of medical data, facilitating informed decision-making and innovative healthcare solutions. With an emphasis on leveraging data for enhanced treatment strategies, SUSMED positions itself as a key player in the movement towards data-driven healthcare.